UBS Group’s Crossmark Large Cap Value ETF CLCV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.91K Sell
96
-58
-38% -$1.79K ﹤0.01% 9912
2026
Q2
$4.61K Sell
154
-56
-27% -$1.62K ﹤0.01% 9025
2026
Q1
$5.56K Buy
+210
New +$5.66K ﹤0.01% 8775

Other funds holding CLCV

UBS Group's CLCV Position: Q3 2026 in Review

UBS Group reduced its Crossmark Large Cap Value ETF (CLCV) stake by 38% in Q3 2026, selling an estimated $1.79K and leaving 96 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #9912.

UBS Group first reported a position in CLCV in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.56K in Q1 2026. 12 funds tracked by Wall St. Rank hold CLCV as of Q3 2026.

  • UBS Group held 96 shares of Crossmark Large Cap Value ETF worth $2.91K as of Q3 2026.
  • UBS Group sold 58 Crossmark Large Cap Value ETF shares in Q3 2026, an estimated $1.79K.
  • Crossmark Large Cap Value ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #9912 holding.
  • UBS Group first reported a position in Crossmark Large Cap Value ETF in Q1 2026 and has held it in 3 quarters since.
  • UBS Group's Crossmark Large Cap Value ETF position peaked at $5.56K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held Crossmark Large Cap Value ETF as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.